Pathophysiology of diastolic dysfunction in chronic heart failure.

about

Mechanisms in cardiovascular diseases: how useful are medical textbooks, eMedicine, and YouTube?Predictors of diastolic dysfunction in rheumatoid arthritis Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure.

P2860

Q28658257-0535E776-1747-4E7A-916B-B07857E6B14C Q35620858-2958D28A-F1AC-4C51-BCC2-68D88DBC817A Q50296013-CE4DE17B-83F5-4BB0-B8A8-378DCEADC72E

P2860

Pathophysiology of diastolic dysfunction in chronic heart failure.

Item

http://www.wikidata.org/entity/Q38135894

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pathophysiology of diastolic dysfunction in chronic heart failure.

@en

type

Item

label

Pathophysiology of diastolic dysfunction in chronic heart failure.

@en

prefLabel

Pathophysiology of diastolic dysfunction in chronic heart failure.

@en

P1476

Pathophysiology of diastolic dysfunction in chronic heart failure.

@en

P2093

Gilles W De Keulenaer

http://www.w3.org/2001/XMLSchema#string

P2860

Five years of GWAS discovery

Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

Biomarkers in heart failure

Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy

Genome-wide association study of blood pressure and hypertension

Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium

Intramyocardial fibroblast myocyte communication.

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.

The IL-33/ST2 pathway: therapeutic target and novel biomarker.

P304

711-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.13.53

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincent Segers

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24020672

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

heart failure

diastole

Pathophysiology of diastolic dysfunction in chronic heart failure.

about

P2860

P2860

Pathophysiology of diastolic dysfunction in chronic heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921